Additional file 1 of HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

Institutions

Publication Details

Journal
Figshare
Published
2025-01-01
DOI
https://doi.org/10.6084/m9.figshare.28423332.v1
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additional file 1 of HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

Figshare
HER2/EGFR in Cancer Research
article

Additional file 1 of HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN

article en

Abstract

No abstract available for this paper.
Figshare
Universität Hamburg (DE), Queen Mary University of London (GB), LMU Klinikum (DE), Medizinische Hochschule Hannover (DE), Universitätsklinikum Erlangen (DE), Elisabeth-Krankenhaus Essen (DE), Exact Sciences (United States) (US), University Medical Center Hamburg-Eppendorf (DE), Essen University Hospital (DE), Klinikum Mutterhaus der Borromäerinnen (DE), Evangelisches Krankenhaus Bethesda Mönchengladbach (DE), Women‘s Healthcare Group (DE), Medizinische Hochschule Brandenburg Theodor Fontane (DE), University Medical Centre Mannheim (DE), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES), Universitat de Barcelona (ES), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE), Saarland University (DE)
Good health and well-being
Openalex Percentile: Top 39%
HER2/EGFR in Cancer Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Additional file 1 of HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN · Figshare (2025) | TGRS Research Map | TGRS